SpectraCure AB (publ)
SSE:SPEC.ST
2.605 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.318 | 0.539 | 0 | 0.001 | 0.001 | 0.596 | 0.259 | 0.173 | 0.779 | 0.476 | 1.49 |
| Cost of Revenue
| 2.662 | -3.046 | -1.385 | -2.35 | -2.617 | -2.125 | -1.553 | -1.138 | -0.249 | -0.642 | 0.068 |
| Gross Profit
| -2.344 | 3.585 | 1.385 | 2.351 | 2.618 | 2.721 | 1.812 | 1.311 | 1.028 | 1.118 | 1.422 |
| Gross Profit Ratio
| -7.371 | 6.651 | 0 | 1,941.545 | 3,430.882 | 4.565 | 6.998 | 7.58 | 1.32 | 2.348 | 0.955 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 11.621 | 10.689 | 8.321 | 7.823 | 6.553 | 5.931 | 5.207 | 5.07 | 3.68 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 21.367 | 11.621 | 10.689 | 8.321 | 7.823 | 6.553 | 5.931 | 5.207 | 5.07 | 3.68 | 4.746 |
| Other Expenses
| 0 | 18.403 | 15.113 | 10.494 | 9.082 | 0.134 | 4.578 | 2.92 | 1.709 | 1.494 | 0 |
| Operating Expenses
| 21.367 | 30.024 | 25.802 | 18.815 | 16.905 | 11.902 | 10.509 | 8.127 | 6.779 | 5.174 | 7.022 |
| Operating Income
| -24.029 | -26.978 | -24.417 | -16.465 | -14.288 | -9.617 | -8.697 | -6.816 | -5.751 | -4.056 | -5.6 |
| Operating Income Ratio
| -75.563 | -50.052 | 0 | -13,596.201 | -18,726.081 | -16.136 | -33.584 | -39.42 | -7.387 | -8.518 | -3.758 |
| Total Other Income Expenses Net
| 4.103 | 1.599 | 1.071 | 1.028 | 0.596 | 0.167 | -0 | 0.444 | -0.134 | -0.29 | -0.132 |
| Income Before Tax
| -19.926 | -25.379 | -23.346 | -15.437 | -13.692 | -9.61 | -8.697 | -6.372 | -5.885 | -4.346 | -5.732 |
| Income Before Tax Ratio
| -62.66 | -47.085 | 0 | -12,747.316 | -17,944.954 | -16.124 | -33.584 | -36.852 | -7.559 | -9.126 | -3.847 |
| Income Tax Expense
| -0.021 | -0.053 | -0.005 | -0.03 | -0.007 | 0.167 | 0 | 0.001 | 0.001 | 0.002 | 0 |
| Net Income
| -20.441 | -25.326 | -23.341 | -15.407 | -13.685 | -9.61 | -8.697 | -6.372 | -5.885 | -4.346 | -5.732 |
| Net Income Ratio
| -64.28 | -46.987 | 0 | -12,722.543 | -17,935.78 | -16.124 | -33.584 | -36.852 | -7.559 | -9.126 | -3.847 |
| EPS
| -0.21 | -0.26 | -0.24 | -0.17 | -0.16 | -0.12 | -0.15 | -0.21 | -0.16 | -0.12 | -0.374 |
| EPS Diluted
| -0.21 | -0.26 | -0.24 | -0.17 | -0.16 | -0.12 | -0.15 | -0.21 | -0.16 | -0.12 | -0.349 |
| EBITDA
| -21.367 | -22.318 | -20.435 | -12.882 | -11.353 | -9.627 | -7.528 | -6.679 | -5.697 | -2.869 | -3.095 |
| EBITDA Ratio
| -67.192 | -41.406 | 0 | -10,637.49 | -14,879.423 | -16.153 | -29.072 | -38.625 | -7.317 | -6.024 | -2.077 |